These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 30977858)

  • 1. Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis.
    D'Andrea E; Hey SP; Ramirez CL; Kesselheim AS
    JAMA Netw Open; 2019 Apr; 2(4):e192224. PubMed ID: 30977858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Niacin in Current Clinical Practice: A Systematic Review.
    Garg A; Sharma A; Krishnamoorthy P; Garg J; Virmani D; Sharma T; Stefanini G; Kostis JB; Mukherjee D; Sikorskaya E
    Am J Med; 2017 Feb; 130(2):173-187. PubMed ID: 27793642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of high-density lipoprotein targeting treatments on cardiovascular outcomes: A systematic review and meta-analysis.
    Riaz H; Khan SU; Rahman H; Shah NP; Kaluski E; Lincoff AM; Nissen SE
    Eur J Prev Cardiol; 2019 Mar; 26(5):533-543. PubMed ID: 30861690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis.
    Silverman MG; Ference BA; Im K; Wiviott SD; Giugliano RP; Grundy SM; Braunwald E; Sabatine MS
    JAMA; 2016 Sep; 316(12):1289-97. PubMed ID: 27673306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of niacin therapy on cardiovascular outcomes in patients with coronary artery disease.
    Duggal JK; Singh M; Attri N; Singh PP; Ahmed N; Pahwa S; Molnar J; Singh S; Khosla S; Arora R
    J Cardiovasc Pharmacol Ther; 2010 Jun; 15(2):158-66. PubMed ID: 20208032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis.
    Bruckert E; Labreuche J; Amarenco P
    Atherosclerosis; 2010 Jun; 210(2):353-61. PubMed ID: 20079494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The current state of niacin in cardiovascular disease prevention: a systematic review and meta-regression.
    Lavigne PM; Karas RH
    J Am Coll Cardiol; 2013 Jan; 61(4):440-446. PubMed ID: 23265337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-Lowering Agents in Older Individuals: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Ponce OJ; Larrea-Mantilla L; Hemmingsen B; Serrano V; Rodriguez-Gutierrez R; Spencer-Bonilla G; Alvarez-Villalobos N; Benkhadra K; Haddad A; Gionfriddo MR; Prokop LJ; Brito JP; Murad MH
    J Clin Endocrinol Metab; 2019 May; 104(5):1585-1594. PubMed ID: 30903687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis.
    Briel M; Ferreira-Gonzalez I; You JJ; Karanicolas PJ; Akl EA; Wu P; Blechacz B; Bassler D; Wei X; Sharman A; Whitt I; Alves da Silva S; Khalid Z; Nordmann AJ; Zhou Q; Walter SD; Vale N; Bhatnagar N; O'Regan C; Mills EJ; Bucher HC; Montori VM; Guyatt GH
    BMJ; 2009 Feb; 338():b92. PubMed ID: 19221140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The therapeutic role of niacin in dyslipidemia management.
    Boden WE; Sidhu MS; Toth PP
    J Cardiovasc Pharmacol Ther; 2014 Mar; 19(2):141-58. PubMed ID: 24363242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins for Prevention of Cardiovascular Disease in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Chou R; Dana T; Blazina I; Daeges M; Jeanne TL
    JAMA; 2016 Nov; 316(19):2008-2024. PubMed ID: 27838722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination niacin and statin therapy in primary and secondary prevention of cardiovascular disease.
    Levy DR; Pearson TA
    Clin Cardiol; 2005 Jul; 28(7):317-20. PubMed ID: 16075823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Niacin and statin combination therapy for atherosclerosis regression and prevention of cardiovascular disease events: reconciling the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) trial with previous surrogate endpoint trials.
    Michos ED; Sibley CT; Baer JT; Blaha MJ; Blumenthal RS
    J Am Coll Cardiol; 2012 Jun; 59(23):2058-64. PubMed ID: 22520249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-lowering therapy in persons with chronic kidney disease: a systematic review and meta-analysis.
    Upadhyay A; Earley A; Lamont JL; Haynes S; Wanner C; Balk EM
    Ann Intern Med; 2012 Aug; 157(4):251-62. PubMed ID: 22910936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrates and niacin: is there a place for them in clinical practice?
    Wierzbicki AS; Viljoen A
    Expert Opin Pharmacother; 2014 Dec; 15(18):2673-80. PubMed ID: 25318657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of HDL-modifiers on cardiovascular outcomes: a meta-analysis of randomized trials.
    Verdoia M; Schaffer A; Suryapranata H; De Luca G
    Nutr Metab Cardiovasc Dis; 2015 Jan; 25(1):9-23. PubMed ID: 25439661
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.